All Qatar Residents to Get Covid Vaccine Free
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Significant Increase in Home-Based Businesses
BUSINESS | 21 SPORT | 27 MHPS to remain Dominant Djokovic Qatar's active wins Shanghai partner: Muyama Masters title Monday 15 October 2018 | 6 Safar I 1440 www.thepeninsula.qa Volume 23 | Number 7680 | 2 Riyals Significant increase in QU’s stellar performance in THE World University Rankings 2019 Total performance indicators home-based businesses used for comparison MOHAMMAD SHOEB The second edition edition, which witnessed the QU placed at THE PENINSULA QU ranked QU achieved in QU was of ‘Made at Home’ participation of 144 local home- 332nd place QS Top 50 under based businesses. The event tar- first in ranked 52 in exhibition will run International in QS World 50 ranking The Asia DOHA: The Minister of Admin- geted a variety of sectors which University among the best istrative Development, Labour were art crafts, technologies, Outlook University until October 20 at Rankings young and Social Affairs H E Dr Issa bin Doha Exhibition and food & beverage, jewelry with Indicator Rankings in Saad Al Jafali Al Nuaimi, who total sales reaching QR2.5m. The 2019 universities Feb 2018 formally inaugurated the second Convention Center. exhibition was attended by more edition of ‘Made at Home’ exhi- than 15,000 visitors across bition yesterday, said that the several nationalities. expo has witnessed a remarkable October 20 at Doha Exhibition The expo is being held under development in all sectors and and Convention Center (DECC), the patronage of H E Sheikha Al products, where over 185 partic- where local micro-businesses and Mayassabint Hamad bin Khalifa ipants are showcasing their home-based manufactures are Al Thani, Chairperson of Qatar products and services. -
Viral Hepatitis Testing Effective Date: January 1, 2012
Viral Hepatitis Testing Effective Date: January 1, 2012 Scope This guideline provides guidance for the use of laboratory tests to diagnose acute and chronic viral hepatitis in adults (> 19 years) in the primary care setting. General Considerations for Ordering Laboratory Tests Prior to ordering tests for hepatitis, consider the patient’s history, age, risk factors (see below), hepatitis vaccination status, and any available previous hepatitis test results. Risk Factors for Viral Hepatitis include: • Substance use (includes sharing drug snorting, smoking or injection equipment) • High-risk sexual activity or sexual partner with viral hepatitis • Travel to or from high-risk hepatitis endemic areas or exposure during a local outbreak • Immigration from hepatitis B and/or C endemic countries • Household contact with an infected person especially if personal items (e.g., razors, toothbrushes, nail clippers) are shared • Recipient of unscreened blood products* • Needle-stick injury or other occupational exposure (e.g., healthcare workers) • Children born to mothers with chronic hepatitis B or C infection • Attendance at daycare • Contaminated food or water (hepatitis A only) • Tattoos and body piercing • History of incarceration • HIV or other sexually transmitted infection • Hemodialysis *screening of donated blood products for hepatitis C (anti-HCV) began in 1990 in Canada.1 Types of Viral Hepatitis Hepatitis A: causes acute but not chronic hepatitis Hepatitis B: causes acute and chronic hepatitis Hepatitis C: causes chronic hepatitis but rarely manifests as acute hepatitis Hepatitis D: rare and only occurs in patients infected with hepatitis B Hepatitis E: clinically similar to hepatitis A, mostly restricted to endemic areas and occasionally causes chronic infection in immunosuppressed people Others: e.g. -
The Use of Non-Human Primates in Research in Primates Non-Human of Use The
The use of non-human primates in research The use of non-human primates in research A working group report chaired by Sir David Weatherall FRS FMedSci Report sponsored by: Academy of Medical Sciences Medical Research Council The Royal Society Wellcome Trust 10 Carlton House Terrace 20 Park Crescent 6-9 Carlton House Terrace 215 Euston Road London, SW1Y 5AH London, W1B 1AL London, SW1Y 5AG London, NW1 2BE December 2006 December Tel: +44(0)20 7969 5288 Tel: +44(0)20 7636 5422 Tel: +44(0)20 7451 2590 Tel: +44(0)20 7611 8888 Fax: +44(0)20 7969 5298 Fax: +44(0)20 7436 6179 Fax: +44(0)20 7451 2692 Fax: +44(0)20 7611 8545 Email: E-mail: E-mail: E-mail: [email protected] [email protected] [email protected] [email protected] Web: www.acmedsci.ac.uk Web: www.mrc.ac.uk Web: www.royalsoc.ac.uk Web: www.wellcome.ac.uk December 2006 The use of non-human primates in research A working group report chaired by Sir David Weatheall FRS FMedSci December 2006 Sponsors’ statement The use of non-human primates continues to be one the most contentious areas of biological and medical research. The publication of this independent report into the scientific basis for the past, current and future role of non-human primates in research is both a necessary and timely contribution to the debate. We emphasise that members of the working group have worked independently of the four sponsoring organisations. Our organisations did not provide input into the report’s content, conclusions or recommendations. -
Rational Engineering of HCV Vaccines for Humoral Immunity
viruses Review To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity Felicia Schlotthauer 1,2,†, Joey McGregor 1,2,† and Heidi E Drummer 1,2,3,* 1 Viral Entry and Vaccines Group, Burnet Institute, Melbourne, VIC 3004, Australia; [email protected] (F.S.); [email protected] (J.M.) 2 Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC 3000, Australia 3 Department of Microbiology, Monash University, Clayton, VIC 3800, Australia * Correspondence: [email protected]; Tel.: +61-392-822-179 † These authors contributed equally to this work. Abstract: Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic vaccine remains a high priority. Whilst early vaccines focused largely on generating T cell immunity, attention is now aimed at vaccines that gen- erate humoral immunity, either alone or in combination with T cell-based vaccines. High-resolution structures of hepatitis C viral glycoproteins and their interaction with monoclonal antibodies isolated from both cleared and chronically infected people, together with advances in vaccine technologies, provide new avenues for vaccine development. Keywords: glycoprotein E2; vaccine development; humoral immunity Citation: Schlotthauer, F.; McGregor, J.; Drummer, H.E To Include or 1. Introduction Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity. The development of direct-acting antiviral agents (DAA) with their ability to cure Viruses 2021, 13, 805. https:// infection in >95% of those treated was heralded as the key to eliminating hepatitis C globally. -
Page 01 Aug 11.Indd
www.thepeninsulaqatar.com BUSINESS | 17 SPORT | 21 Central banks Pakistan ponder can’t just dial up line-up for England growth: Stevens finale at The Oval THURSDAY 11 AUGUST 2016 • 8 DHUL QA’DA 1437 • Volume 21 • Number 6885 2 Riyals thepeninsulaqatar @peninsulaqatar @peninsula_qatar PM meets Kuwait envoy Emir sends greetings Three regional to Ecuador President DOHA: Emir H H Sheikh Tamim bin Hamad Al Thani sent a cable of congratulations to President of the hospitals help Republic of Ecuador Rafael Cor- rea Delgado on the anniversary of his country’s Independence Day. reduce HGH rush Barwa awards ‘Dara A’ project to QDTC Cuban ( in Dukhan) hospitals are DOHA: Barwa Real Estate has bringing quality health care closer announced the award of the con- The demand for to the communities. So patients have struction of “Dara A” project to services at the to travel to Doha only for complex Qatar Development Company for care,” an HMC spokesman said yes- Trading & Contracting (QDTC) for Hamad General terday citing 2015 data on hospital a total value of QR115,9m and a visits. Last year, Al Wakra Hospi- duration of 18 months. The Dara A Hospital (HGH) has Prime Minister and Interior Minister H E Sheikh Abdullah bin Nasser bin Khalifa Al Thani with Ambassador also increased as tal recorded the highest number of project is located in the Northern visits at its Outpatient Department of Kuwait Mutib Saleh Al Mutawtah on the occasion of ending his tenure in Qatar. The Prime Minister part of Fox Hills in Lusail City. Qatar’s population (OPD). -
Research Directions After the First Hepatitis C Vaccine Efficacy Trial
viruses Review Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial Christopher C. Phelps 1 , Christopher M. Walker 1,2 and Jonathan R. Honegger 1,2,*,† 1 Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children’s Hospital, Columbus, OH 43205, USA; [email protected] (C.C.P.); [email protected] (C.M.W.) 2 Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH 43210, USA * Correspondence: [email protected] † Current address: Abigail Wexner Research Institute at Nationwide Children’s Hospital, 700 Children’s Drive, WA4020, Columbus, OH 43205, USA. Abstract: Thirty years after its discovery, the hepatitis C virus (HCV) remains a leading cause of liver disease worldwide. Given that many countries continue to experience high rates of transmission despite the availability of potent antiviral therapies, an effective vaccine is seen as critical for the elimination of HCV. The recent failure of the first vaccine efficacy trial for the prevention of chronic HCV confirmed suspicions that this virus will be a challenging vaccine target. Here, we examine the published data from this first efficacy trial along with the earlier clinical and pre-clinical studies of the vaccine candidate and then discuss three key research directions expected to be important in ongoing and future HCV vaccine development. These include the following: 1. design of novel immunogens that generate immune responses to genetically diverse HCV genotypes and subtypes, 2. strategies to elicit broadly neutralizing antibodies against envelope glycoproteins in addition to cytotoxic and helper T cell responses, and 3. -
1 Title: Interim Report of a Phase 2 Randomized Trial of a Plant
medRxiv preprint doi: https://doi.org/10.1101/2021.05.14.21257248; this version posted May 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. 1 Title: Interim Report of a Phase 2 Randomized Trial of a Plant-Produced Virus-Like Particle 2 Vaccine for Covid-19 in Healthy Adults Aged 18-64 and Older Adults Aged 65 and Older 3 Authors: Philipe Gobeil1, Stéphane Pillet1, Annie Séguin1, Iohann Boulay1, Asif Mahmood1, 4 Donald C Vinh 2, Nathalie Charland1, Philippe Boutet3, François Roman3, Robbert Van Der 5 Most4, Maria de los Angeles Ceregido Perez3, Brian J Ward1,2†, Nathalie Landry1† 6 Affiliations: 1 Medicago Inc., 1020 route de l’Église office 600, Québec, QC, Canada, G1V 7 3V9; 2 Research Institute of the McGill University Health Centre, 1001 Decarie St, Montreal, 8 QC H4A 3J1; 3 GlaxoSmithKline Biologicals SA (Vaccines), Avenue Fleming 20, 1300 Wavre, 9 Belgium; 4 GlaxoSmithKline Biologicals SA (Vaccines), rue de l’Institut 89, 1330 Rixensart, 10 Belgium; † These individuals are equally credited as senior authors. 11 * Corresponding author: Nathalie Landry, 1020 Route de l’Église, Bureau 600, Québec, Qc, 12 Canada, G1V 3V9; Tel. 418 658 9393; Fax. 418 658 6699; [email protected] 13 Abstract 14 The rapid spread of SARS-CoV-2 globally continues to impact humanity on a global scale with 15 rising morbidity and mortality. Despite the development of multiple effective vaccines, new 16 vaccines continue to be required to supply ongoing demand. -
Amir Commissions World's Largest Water Reservoirs
WEDNESDAY DECEMBER 12, 2018 RABI AL-AKHIR 5, 1440 VOL.12 NO. 4481 QR 2 FINE Fajr: 4:47 am Dhuhr: 11:28 am HIGH : 26°C Asr: 2:26 pm Maghrib: 4:46 pm LOW : 19°C Isha: 6:16 pm Business 12 Sports 16 IBPC launches first edition of Al Sadd end Al Duhail’s Business Excellence Awards winning run, top table AMIR COMMISSIONS WORLD’S LARGEST WATER RESERVOIRS PROJECT QNA Single reservoir dimensions DOHA The world largest reservoir of its QR14.5 bn project to raise water storage capacity to 1,500 mn gallons A GIGIANANT LELEAPAP kind: 300m long, 150m wide, and 12m high (equivalent to the size THE Amir HH Sheikh Tamim of 9 football fields) bin Hamad al Thani inaugu- TOTOWAWARRDDS rated the Water Security Mega Around 100 MIG Reservoirs Project during a cer- WAWATETER SESECCUURIRITYTY is one reservoir’s capacity emony held by Qatar General Electricity and Water Corpora- STORAGE CAPACITY Guinness World Record tion (Kahramaa) in Umm Salal The total capacity of the reservoirs project World largest drinking water Ali area on Tuesday. is 1,500 million gallons (MIG), an increase of storage tank & largest drinking During the ceremony, a 155% over the current capacity (900 MIG) water storage tanks network short film was screened about the strategic importance of the Covers storage requirements up to 2026 PROJECT COST project, which is the largest of FIVE STRATEGIC SITES QR14.5bn its kind in the region and the The total cost of the project world with a total capacity of Each site covers 1 sqkm storing about 1,500 million gal- Total reservoirs at all sites: 15 QR1.5bn lons of water, the workload and Umm Birka reservoirs the stages of its development QR2bn since 2015. -
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines
Review Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines Puna Maya Maharjan 1 and Sunghwa Choe 2,3,* 1 G+FLAS Life Sciences, 123 Uiryodanji-gil, Osong-eup, Heungdeok-gu, Cheongju-si 28161, Korea; punamaya.maharjan@gflas.com 2 G+FLAS Life Sciences, 38 Nakseongdae-ro, Gwanak-gu, Seoul 08790, Korea 3 School of Biological Sciences, College of Natural Sciences, Seoul National University, Gwanak-gu, Seoul 08826, Korea * Correspondence: [email protected] Abstract: The prevalence of the coronavirus disease 2019 (COVID-19) pandemic in its second year has led to massive global human and economic losses. The high transmission rate and the emergence of diverse SARS-CoV-2 variants demand rapid and effective approaches to preventing the spread, diagnosing on time, and treating affected people. Several COVID-19 vaccines are being developed using different production systems, including plants, which promises the production of cheap, safe, stable, and effective vaccines. The potential of a plant-based system for rapid production at a commercial scale and for a quick response to an infectious disease outbreak has been demonstrated by the marketing of carrot-cell-produced taliglucerase alfa (Elelyso) for Gaucher disease and tobacco- produced monoclonal antibodies (ZMapp) for the 2014 Ebola outbreak. Currently, two plant-based COVID-19 vaccine candidates, coronavirus virus-like particle (CoVLP) and Kentucky Bioprocessing (KBP)-201, are in clinical trials, and many more are in the preclinical stage. Interim phase 2 clinical Citation: Maharjan, P.M.; Choe, S. trial results have revealed the high safety and efficacy of the CoVLP vaccine, with 10 times more Plant-Based COVID-19 Vaccines: neutralizing antibody responses compared to those present in a convalescent patient’s plasma. -
Flu Vaccine Safe and Need of the Hour
BUSINESS | Page 1 SPORT | Page 1 Al Khaliji Al Naama scores net pips Gtnah profi t of in Umm Bab QR544mn Cup thriller published in QATAR since 1978 FRIDAY Vol. XXXXI No. 11710 October 23, 2020 Rabia I 6, 1442 AH GULF TIMES www. gulf-times.com 2 Riyals In brief PM visits S’hail 2020 exhibition Flu vaccine Infantino rules out holding Qatar World Cup without fans FIFA President Gianni Infantino safe and need yesterday ruled out hosting the 2022 World Cup in Qatar without fans. The competition will take place in winter for the first time-ever from November 21 to December 18. Infantino told journalists of the hour: in Zurich that there will be enough time by the end of 2022 to contain the coronavirus pandemic. He noted that while the health crisis represents a threat to football now, it should be top offi cial contained by the time the World Cup arrives. he fl u virus can cause severe “We have also begun offering the Registration for illness for some people, espe- vaccine to the public, and especially winter camping Tcially those at increased risk to those aged 50 years or above, for developing infl uenza-related children from six months to five reopens on Sunday complications, Dr Abdullatif al-Khal, years of age, people with chronic The Ministry of Municipality and head of the Infectious Diseases Divi- diseases, and pregnant women at Environment (MME) has announced sion at Hamad Medical Corporation all stages of pregnancy,” Dr al-Khal that it will reopen registration for (HMC), cautioned yesterday. -
Page 01 Jan 23.Indd
3rd Best News Website in the Middle East BUSINESS | 17 SPORT | 25 Lulu Group AFC U-23 semi-final: partners with World Qatar raring to go Economic Forum against Vietnam Tuesday 23 January 2018 | 6 Jumada 1 | 1439 www.thepeninsula.qa Volume 22 | Number 7415 | 2 Riyals Get inclusive with the new Fibre Plans! Qatar-EU air & Emir meets GECF Secretary-General Qatar’s AG meets FBI sea freight lane Director, US Senator to grow faster QNA SATISH KANADY The EU-Qatar air WASHINGTON: Attorney THE PENINSULA freight lane is General of the State of Qatar, H E Dr. Ali bin Fetais Al Marri, DOHA: The Qatar-EU trade forecast to grow who is currently on his lane has been projected as one by 39.4%, while official visit to Washington, of the busiest routes, both in Qatar-EU sea freight met with the Director of US terms of air and sea freight air lane is projected Federal Bureau of Investi- lanes, in the Emerging Market. gation (FBI), Christopher The EU-Qatar air freight to expand by a Wray. lane is forecast to grow by 39.4 whopping 121.7 During the meeting, both percent, while Qatar-EU sea percent. the parties discussed a freight air lane is projected to number of issues pertaining expand by a whopping 121.7 to common concern on percent. which they cooperate, as The annual Emerging EU-Ukraine (+40.9 percent), well as ways of dealing with Markets Logistics Index, EU-Qatar (+39.4 percent), EU- Emir H H Sheikh Tamim bin Hamad Al Thani meeting with Secretary General of Gas Exporting Countries some other issues. -
Patient Experience Forum to Be Held on November 16 and 17 Sidra Medicine, Qatar University, Safety
BUSINESSBU | 01 SPORT | 10 QQIIB optimistic Doha events have on growth, become a benchmark expansion for other venues to in 2019 rival: QGF President Monday 25 March 2019 | 18 Rajab 1440 www.thepeninsula.qa Volume 24 | Number 7841 | 2 Riyals New Ooredoo tv Play like a pro Google, Android, Android TV, Chromecast and other related marks and logos are trademarks of Google LLC. Amir to patronise opening of Umm Al Houl Power Plant today THE PENINSULA The project will generate As Qatar is focusing on completion DOHA of strategic projects to meet goals set a daily production under Qatar National Vision 2030, Amir H H Sheikh Tamim bin Hamad Al capacity of 136m gallons H H the Amir in December last year Thani will patronise today the opening of water and 2,520MW also inaugurated the Water Security ceremony of the Umm Al Houl power of electricity. Its full Mega Reservoirs Project, which is the plant, in Umm Al Houl area, south of Al largest of its kind in the world in Umm Wakrah. production capacity will Salal Ali. The QR14.5bn project has a The QR11bn Umm Al Houl Power supply Qatar’s 30 percent total water storage capacity of about project is one of the largest desalination of electricity needs and 1,500m gallons, and was implemented and power generation plants in the 40 percent of water by Qatar General Electricity and Water region. Corporation (Kahramaa). The project will generate a daily requirements. The project is the largest in the production capacity of 136m gallons of world and contains a huge strategic water and 2,520MW of electricity.